Published in BMC Microbiol on May 12, 2016
Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. Microbiome (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
The KEGG databases at GenomeNet. Nucleic Acids Res (2002) 33.68
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res (2010) 13.68
SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics (1998) 11.91
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics (2010) 6.57
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res (2011) 5.58
Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10
VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res (2005) 4.77
Bacterial cell wall synthesis: new insights from localization studies. Microbiol Mol Biol Rev (2005) 3.72
ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother (2013) 3.47
The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol (1984) 3.45
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. J Bacteriol (2002) 3.18
Non-classical protein secretion in bacteria. BMC Microbiol (2005) 3.17
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res (2011) 3.05
Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci (2004) 3.02
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms. Nat Protoc (2008) 2.89
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis (2011) 2.62
Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun (2000) 2.55
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov (2008) 2.36
Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe (2013) 2.22
DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics (2012) 2.14
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun (2000) 2.11
Microbes, microbiota, and colon cancer. Cell Host Microbe (2014) 2.06
DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res (2013) 2.01
Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev (1996) 1.99
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity (2015) 1.92
Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem (2014) 1.90
PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics (2005) 1.82
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res (2009) 1.82
Term stillbirth caused by oral Fusobacterium nucleatum. Obstet Gynecol (2010) 1.73
Poly-gamma-glutamate in bacteria. Mol Microbiol (2006) 1.72
Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol (2011) 1.69
Structural perspective of peptidoglycan biosynthesis and assembly. Annu Rev Biochem (2012) 1.69
HPIDB--a unified resource for host-pathogen interactions. BMC Bioinformatics (2010) 1.31
Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res (2014) 1.30
Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol (2007) 1.28
Genome analysis of F. nucleatum sub spp vincentii and its comparison with the genome of F. nucleatum ATCC 25586. Genome Res (2003) 1.28
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement (2012) 1.28
Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. PLoS One (2013) 1.24
Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun (2005) 1.24
A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis. Infect Immun (1984) 1.15
Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect Immun (1998) 1.14
Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol (2011) 1.12
Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours. Br J Cancer (2004) 1.11
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease. Neurochem Res (2009) 1.10
Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium. PLoS One (2007) 1.06
The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose. J Bacteriol (2000) 1.02
A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). J Biol Chem (2005) 0.99
Association between hypertension and periodontitis: possible mechanisms. ScientificWorldJournal (2014) 0.96
Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96
Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun (1995) 0.95
Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol (2011) 0.94
Pyogenic liver abscess after colonoscopy in a patient with ulcerative colitis. Clin Gastroenterol Hepatol (2005) 0.94
Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect Immun (1999) 0.93
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
Fusobacterium nucleatum GroEL induces risk factors of atherosclerosis in human microvascular endothelial cells and ApoE(-/-) mice. Mol Oral Microbiol (2011) 0.90
Proteomic analysis of ampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiol Immunol (2008) 0.90
The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity. Clin Vaccine Immunol (2012) 0.89
The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls. Structure (1996) 0.89
Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem (2010) 0.88
Multiple brain abscesses caused by Fusobacterium nucleatum treated conservatively. Can J Neurol Sci (2003) 0.85
Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeri in an immunocompetent adult: a case report and literature review. BMC Infect Dis (2012) 0.85
Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother (2003) 0.85
Identification of a Fusobacterium nucleatum 65 kDa serine protease. Oral Microbiol Immunol (2004) 0.84
Polysaccharide biosynthesis protein CapD is a novel pathogenicity-associated determinant of Haemophilus parasuis involved in serum-resistance ability. Vet Microbiol (2013) 0.84
Molecular basis of host specificity in human pathogenic bacteria. Emerg Microbes Infect (2014) 0.84
Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation. J Immunol (2007) 0.82
Porphyromonas gingivalis, Treponema denticola and toll-like receptor 2 are associated with hypertensive disorders in placental tissue: a case-control study. J Periodontal Res (2013) 0.82
Cardiovascular disease and the role of oral bacteria. J Oral Microbiol (2010) 0.81
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget (2015) 0.80
Myocardial infection due to Fusobacterium nucleatum. Diagn Microbiol Infect Dis (2013) 0.79
Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors. Biochemistry (2004) 0.79
Gene essentiality analysis based on DEG 10, an updated database of essential genes. Methods Mol Biol (2015) 0.78
Screening and sequence analysis of the hemolysin gene of Fusobacterium necrophorum. Anaerobe (2010) 0.78
Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Infect Genet Evol (2011) 0.78
The function of the bacterial cytoskeleton in Salmonella pathogenesis. Virulence (2012) 0.76